Clinical Trial Update: Bevacizumab and Carboplatin for Patients With Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab in combination with carboplatin for ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Vejle Hospital | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED